Guangdong Kanghua Healthcare Group Management
Management criteria checks 4/4
We currently do not have sufficient information about the CEO.
Key information
Wangzhi Chen
Chief executive officer
CN¥1.5m
Total compensation
| CEO salary percentage | 85.7% |
| CEO tenure | 9yrs |
| CEO ownership | n/a |
| Management average tenure | 8.5yrs |
| Board average tenure | 9yrs |
Recent management updates
Shareholders May Find It Hard To Justify Increasing Guangdong Kanghua Healthcare Co., Ltd.'s (HKG:3689) CEO Compensation For Now
Jun 19
Key Things To Understand About Guangdong Kanghua Healthcare's (HKG:3689) CEO Pay Cheque
Dec 14Recent updates
Guangdong Kanghua Healthcare Group Co., Ltd.'s (HKG:3689) Popularity With Investors Is Under Threat From Overpricing
Dec 20Here's Why Guangdong Kanghua Healthcare Group (HKG:3689) Can Manage Its Debt Responsibly
Nov 25There May Be Some Bright Spots In Guangdong Kanghua Healthcare Group's (HKG:3689) Earnings
Sep 30Shareholders May Find It Hard To Justify Increasing Guangdong Kanghua Healthcare Co., Ltd.'s (HKG:3689) CEO Compensation For Now
Jun 19Does Guangdong Kanghua Healthcare (HKG:3689) Deserve A Spot On Your Watchlist?
Jun 10Guangdong Kanghua Healthcare Co., Ltd.'s (HKG:3689) Share Price Boosted 28% But Its Business Prospects Need A Lift Too
May 22Capital Allocation Trends At Guangdong Kanghua Healthcare (HKG:3689) Aren't Ideal
Nov 28Returns On Capital Signal Tricky Times Ahead For Guangdong Kanghua Healthcare (HKG:3689)
May 09Capital Allocation Trends At Guangdong Kanghua Healthcare (HKG:3689) Aren't Ideal
Feb 02Here's Why Guangdong Kanghua Healthcare (HKG:3689) Can Manage Its Debt Responsibly
Nov 08Some Investors May Be Worried About Guangdong Kanghua Healthcare's (HKG:3689) Returns On Capital
Sep 06Investors Could Be Concerned With Guangdong Kanghua Healthcare's (HKG:3689) Returns On Capital
May 31Returns On Capital Signal Tricky Times Ahead For Guangdong Kanghua Healthcare (HKG:3689)
Jan 25Capital Allocation Trends At Guangdong Kanghua Healthcare (HKG:3689) Aren't Ideal
Sep 21Is Guangdong Kanghua Healthcare (HKG:3689) Using Too Much Debt?
May 03Do Insiders Own Lots Of Shares In Guangdong Kanghua Healthcare Co., Ltd. (HKG:3689)?
Feb 04
Key Things To Understand About Guangdong Kanghua Healthcare's (HKG:3689) CEO Pay Cheque
Dec 14CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | CN¥51m |
| Mar 31 2024 | n/a | n/a | CN¥86m |
| Dec 31 2023 | CN¥1m | CN¥1m | CN¥121m |
| Sep 30 2023 | n/a | n/a | CN¥118m |
| Jun 30 2023 | n/a | n/a | CN¥115m |
| Mar 31 2023 | n/a | n/a | CN¥87m |
| Dec 31 2022 | CN¥2m | CN¥1m | CN¥60m |
| Sep 30 2022 | n/a | n/a | CN¥59m |
| Jun 30 2022 | n/a | n/a | CN¥59m |
| Mar 31 2022 | n/a | n/a | CN¥76m |
| Dec 31 2021 | CN¥2m | CN¥1m | CN¥94m |
| Sep 30 2021 | n/a | n/a | CN¥103m |
| Jun 30 2021 | n/a | n/a | CN¥112m |
| Mar 31 2021 | n/a | n/a | CN¥43m |
| Dec 31 2020 | CN¥2m | CN¥2m | -CN¥25m |
| Sep 30 2020 | n/a | n/a | -CN¥63m |
| Jun 30 2020 | n/a | n/a | -CN¥100m |
| Mar 31 2020 | n/a | n/a | -CN¥13m |
| Dec 31 2019 | CN¥2m | CN¥2m | CN¥74m |
| Sep 30 2019 | n/a | n/a | CN¥112m |
| Jun 30 2019 | n/a | n/a | CN¥150m |
| Mar 31 2019 | n/a | n/a | CN¥159m |
| Dec 31 2018 | CN¥2m | CN¥2m | CN¥168m |
| Sep 30 2018 | n/a | n/a | CN¥169m |
| Jun 30 2018 | n/a | n/a | CN¥170m |
| Mar 31 2018 | n/a | n/a | CN¥163m |
| Dec 31 2017 | CN¥1m | CN¥792k | CN¥157m |
Compensation vs Market: Wangzhi's total compensation ($USD201.41K) is about average for companies of similar size in the Hong Kong market ($USD230.70K).
Compensation vs Earnings: Wangzhi's compensation has been consistent with company performance over the past year.
CEO
Wangzhi Chen (53 yo)
9yrs
Tenure
CN¥1,470,000
Compensation
Mr. Wangzhi Chen is Co-Owner of Dongguan Xingda Property Investment Co., Ltd. Mr. Chen serves as Chief Executive Officer of Guangdong Kanghua Healthcare Co., Ltd. Mr. Chen has been Executive Director at Gu...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman of the Board | 9yrs | CN¥180.00k | 66.54% HK$ 400.5m | |
| CEO & Executive Director | no data | CN¥1.47m | no data | |
| Executive Vice Chairman | 9yrs | CN¥180.00k | no data | |
| Executive Director | no data | CN¥303.00k | no data | |
| CFO, Joint Company Secretary & Secretary to the Board | 9yrs | no data | no data | |
| Vice General Manager of Operation | 8.5yrs | no data | no data | |
| Joint Company Secretary | 8.5yrs | no data | no data | |
| Financial Controller | 8.5yrs | no data | no data |
8.5yrs
Average Tenure
48.5yo
Average Age
Experienced Management: 3689's management team is seasoned and experienced (8.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman of the Board | 9yrs | CN¥180.00k | 66.54% HK$ 400.5m | |
| CEO & Executive Director | 9yrs | CN¥1.47m | no data | |
| Executive Vice Chairman | 9yrs | CN¥180.00k | no data | |
| Executive Director | 9yrs | CN¥303.00k | no data | |
| Independent Non-Executive Director | 8.5yrs | CN¥120.00k | no data | |
| Independent Non-Executive Director | 9yrs | CN¥120.00k | no data | |
| Non-Executive Director | 8.5yrs | no data | no data | |
| Independent Non-Executive Director | 8.5yrs | CN¥120.00k | no data | |
| Chairman of the Supervisory Committee | 9yrs | no data | no data | |
| Member of Supervisory Committee | 9yrs | no data | no data | |
| Member of Supervisory Committee | 6.2yrs | no data | no data |
9.0yrs
Average Tenure
49yo
Average Age
Experienced Board: 3689's board of directors are considered experienced (9 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 14:42 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Guangdong Kanghua Healthcare Group Co., Ltd. is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ruyi Tang | BOCI Research Ltd. |
| Jing Qiang | China International Capital Corporation Limited |
| Yue-Kwong Lui | China Renaissance Securities |